Massmutual Trust Co. FSB ADV Has $624,000 Stock Position in Agilent Technologies, Inc. (NYSE:A)

Massmutual Trust Co. FSB ADV cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 33.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,204 shares of the medical research company’s stock after selling 2,148 shares during the quarter. Massmutual Trust Co. FSB ADV’s holdings in Agilent Technologies were worth $624,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of A. Jones Financial Companies Lllp bought a new stake in shares of Agilent Technologies in the fourth quarter valued at about $49,000. Lake Street Advisors Group LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $218,000. Public Employees Retirement Association of Colorado lifted its position in shares of Agilent Technologies by 1,027.2% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 43,914 shares of the medical research company’s stock worth $6,105,000 after acquiring an additional 40,018 shares during the period. Cibc World Markets Corp grew its holdings in shares of Agilent Technologies by 131.0% during the 4th quarter. Cibc World Markets Corp now owns 37,668 shares of the medical research company’s stock worth $5,237,000 after purchasing an additional 21,365 shares in the last quarter. Finally, Pinebridge Investments L.P. increased its position in shares of Agilent Technologies by 10.2% during the fourth quarter. Pinebridge Investments L.P. now owns 21,136 shares of the medical research company’s stock valued at $2,938,000 after purchasing an additional 1,963 shares during the period. 87.42% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on A. Bank of America lifted their price target on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Evercore ISI upped their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday. UBS Group raised their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Stifel Nicolaus reiterated a “buy” rating and issued a $151.00 price objective on shares of Agilent Technologies in a research note on Monday, August 26th. Finally, Wells Fargo & Company assumed coverage on Agilent Technologies in a report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price for the company. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $143.64.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,953 shares of company stock valued at $2,013,630. 0.33% of the stock is currently owned by insiders.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $144.97 on Friday. The business has a fifty day moving average of $140.12 and a 200-day moving average of $139.09. The firm has a market cap of $42.30 billion, a PE ratio of 34.27, a price-to-earnings-growth ratio of 6.48 and a beta of 1.05. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.43 earnings per share. On average, equities research analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be issued a $0.236 dividend. The ex-dividend date of this dividend is Tuesday, October 1st. This represents a $0.94 annualized dividend and a yield of 0.65%. Agilent Technologies’s dividend payout ratio is currently 22.22%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.